3 hrs ago
IPO Report: Autohome
Autohome is the leading online destination for automobile consumers in China . Through its two websites, autohome.com .cn and che168.com , ATHM delivers comprehensive, independent and interactive content to automobile buyers and owners.
Tue Dec 10, 2013
ANI Pharmaceuticals Presents At Oppenheimer 24th Annual Healthcare Conference
ANI Pharmaceuticals, Inc. presented at the Oppenheimer & Co. 24 Annual Healthcare Conference at the Crowne Plaza Hotel in New York City.
Sequenom's Management Presents at Oppenheimer & Co. Inc. 24th Annual...
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Mon Dec 09, 2013
TravelCenters of America LLC Announces Public Offering of 5,000,000 Common Shares
TravelCenters of America LLC today announced that it has commenced a public offering of 5,000,000 common shares.
Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares
Celldex Therapeutics, Inc. today announced that the underwriters of its previously announced public offering of common stock have exercised in full their option to purchase an additional 1,050,000 additional shares of common stock at the public offering price of $24.50.
The Washington Post
Oppenheimer's Sirianni Suspended for Muni-Bond Price Gouging
David Sirianni, Oppenheimer Holdings Inc.'s head municipal bond trader, was fined $100,000 and suspended for 60 days by the Financial Industry Regulatory Authority for overcharging customers.
NPS Pharmaceuticals, Inc. To Present At Oppenheimer Healthcare Conference
NPS Pharmaceuticals, Inc. will present at the Oppenheimer 24th Annual Healthcare Conference in New York on Tuesday, December 10, 2013 at 9:10 a.m. ET.
Sat Dec 07, 2013
Worcester Telegram & Gazette
TSA cancels $60M order for OSI baggage scanners
OSI Systems Inc., one of the U.S. Transportation Security Administration's top contractors for airport equipment, fell the most in almost six months after a $60 million order for screening machines was canceled.
Thu Dec 05, 2013
Auxilium Pharmaceuticals, Inc. To Present At The Oppenheimer Conference
Auxilium Pharmaceuticals, Inc. today announced that executive management will participate in the Oppenheimer 24 Annual Conference to be held December 10-11, 2013 at the Crown Plaza in New York.
/ CORRECTION - NewLink Genetics to Present at the Oppenheimer 24th Annual Healthcare Conference
The headline has also been updated. Complete corrected text follows. AMES, IA -- Dec 5, 2013 -- NewLink Genetics Corporation , a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutics to improve treatment options for patients with cancer, announced today that Charles J. Link, Jr., M.D., NewLink's ... (more)
Iroko Pharmaceuticals to Present at Oppenheimer 24th Annual Healthcare Conference
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company will be presenting at the Oppenheimer & Co.
Wed Dec 04, 2013
A.P. Pharma Announces Proposed Underwritten Offering of Common Stock
By a News Reporter-Staff News Editor at Biotech Week -- A.P. Pharma, Inc. , a specialty pharmaceutical company, announced its intention to offer and sell shares of its common stock to "Qualified Institutional Buyers" in an underwritten offering pursuant to its existing shelf registration statement.
Celldex Therapeutics Prices Public Offering of Common Stock
Celldex Therapeutics, Inc. today announced the pricing of an underwritten public offering of 7,000,000 shares of its common stock, offered at a price to the public of $24.50 per share for an aggregate offering of $171,500,000 of common stock.
Oppenheimer adds Fair Trade pepper
Guadalajara, Mexico-based Divemex, whose peppers are marketed by The Oppenheimer Group, has added a Fair Trade-certified green pepper to its existing mix of red, yellow and orange.
Regeneron Announces Upcoming 2013 Investor Conference Presentation
Regeneron Pharmaceuticals, Inc. will webcast its presentation at the Oppenheimer 24 Annual Healthcare Conference on Wednesday, December 11, 2013.
Zogenix to Present at the Oppenheimer 24th Annual Healthcare Conference
Zogenix, Inc. , a pharmaceutical company developing and commercializing products for the treatment of central nervous system disorders and pain, today announced that Ann Rhoads, Chief Financial Officer will present at the Oppenheimer 24th Annual Healthcare Conference in New York on December 11, 2013.
Tue Dec 03, 2013
StoneCastle Financial Corp. Announces Partial Exercise of Overallotment Option
NEW YORK, Dec. 3, 2013 -- StoneCastle Financial Corp. today announced that the underwriters of its initial public offering exercised a portion of their overallotment option and purchased an additional 125,000 shares of common stock, to be sold at $25 per share.
Cleveland BioLabs to Present at Oppenheimer 24th Annual Healthcare Conference
Cleveland BioLabs, Inc. today announced that the Company is scheduled to present at the Oppenheimer & Co.
Mon Dec 02, 2013
The Medicines Company To Participate In Upcoming Investor Conference Webcasts
The Medicines Company is scheduled to present at the 25th Annual Piper Jaffray Healthcare Conference on December 4th at 12:30 PM Eastern Time.
Cempra, Inc. to Present at Piper Jaffray 25th Annual Healthcare...
Cempra, Inc. today announced that Prabhavathi Fernandes, Ph.D., chief executive officer of Cempra, will present at the Piper Jaffray 25th Annual Healthcare Conference at 2:30 p.m. EST, Wednesday, Dec. 4, at The New York Palace Hotel, and at the Oppenheimer 24th Annual Healthcare Conference at 3:55 p.m. EST, Wednesday, Dec. 11, at The Crowne Plaza ... (more)